Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sonnet BioTherapeutics Holdings, Inc. - Common Stock (NQ:SONN)

1.170 -0.010 (-0.85%)
Streaming Delayed Price Updated: 3:59 PM EDT, May 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Sonnet BioTherapeutics Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Sonnet BioTherapeutics Regains Nasdaq Minimum Bid Price Compliance
Via ACCESSWIRE
Stocks That Hit 52-Week Lows On Monday
  Monday's session saw 175 companies set new 52-week lows. 
Via Benzinga
Why Sonnet BioTherapeutics Stock (SONN) Is Getting Obliterated
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 24% to $0.21 Thursay afternoon after the company announced a 1-for-22 reverse stock split. 
Via Benzinga
Expert Ratings for Sonnet BioTherapeutics
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 57 companies reached new 52-week lows. 
Via Benzinga
Sonnet BioTherapeutics Announces 1-for-22 Reverse Stock Split
Via ACCESSWIRE
7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
There are some solid biotech stocks on the market. But there are many more that deserve an “F” rating from the Portfolio Grader. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Tower Semiconductor Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
What's Going On With Sonnet BioTherapeutics Stock Today?
Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) shares are trading higher after the company announced that the IND for SB221, the Phase 1b/2a trial of SON-1010 (IL12-FHAB) in combination with Roche... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Sonnet BioTherapeutics Announces FDA Acceptance of the Company's IND for the SB221 Clinical Trial of SON-1010 Combined with Atezolizumab in the US
Via ACCESSWIRE
Sonnet BioTherapeutics Provides Fiscal Year 2023 Third Quarter Business and Earnings Update
Via ACCESSWIRE
Why TETRA Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Gainers American Superconductor Corporation (NASDAQ: AMSC) shares surged 112.1% to $21.38 in pre-market trading. AMSC is expected to report first-quarter results on Aug. 9, 2023. 
Via Benzinga
Why Is SOFI Stock Up 19% Today?
SoFi Technologies (SOFI) stock is on the rise Monday after the financial services company released results for the second quarter of 2023! 
Via InvestorPlace
Why Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today?
Sonnet BioTherapeutics (SONN) stock is taking a beating on Monday after the company announced details for a public stock offering. 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Sonnet BioTherapeutics to Present at the 2023 BTIG Virtual Biotechnology Conference
Via ACCESSWIRE
Why China Natural Resources Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
It's time to start off the week with a breakdown of the biggest pre-market stock movers worth watching for Monday morning! 
Via InvestorPlace
Crude Oil Rises Sharply; Unifirst Earnings Miss Expectations
U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 100 points on Wednesday. The Dow traded down 0.32% to 33,818.48 while the NASDAQ rose 0.23% to 13,586.93. The S&P... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why Eton Pharmaceuticals Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) surged 46.2% to $8.80. Minerva Neurosciences announced $20 million in private placement priced at a premium to market. 
Via Benzinga
Nasdaq Moves Higher; US Crude Stocks Drop More than Projected
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining over 80 points on Wednesday. The Dow traded down 0.42% to 33,784.59 while the NASDAQ rose 0.63% to 13,640.83. The S&P... 
Via Benzinga
Why Sonnet BioTherapeutics (SONN) Stock Is Nosediving
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares are trading lower by 26.18% to $0.50 Wednesday morning after announcing a $2.25 million registered direct offering of 5 million 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Sonnet BioTherapeutics Announces $2.25 Million Registered Direct Offering and Concurrent Private Placement
Via ACCESSWIRE
Why CarMax Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Kidpik Corp. (NASDAQ: PIK) shares jumped 122% to $1.29. Kidpik teamed up with Disney to celebrate the release of Disney+ original movie 'World's Best'. 
Via Benzinga
Why Virgin Galactic Are Trading Lower By Around 18%; Here Are 20 Stocks Moving Premarket
Gainers Castellum, Inc. (NYSE: CTM) shares surged 176.6% to $1.25 in pre-market trading after dropping around 6% on Thursday. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.